Recent articles on Influenza from key Wiley-Blackwell journals – FREE TO ALL
Evaluation of twenty rapid antigen tests for the detection of human influenza A H5N1, H3N2, H1N1, and B viruses
Janette Taylor, Kenneth McPhie, Julian Druce, Chris Birch, Dominic E. Dwyer
Journal of Medical Virology, Volume 81, Issue 11, Date: November 2009, Pages: 1918-1922
Surveillance and oseltamivir resistance of human influenza a virus in Turkey during the 2007-2008 season
Meral Akcay Ciblak, Mustafa Hasoksuz, Vanessa Escuret, Martine Valette, Fadime Gul, Huseyin Yilmaz, Nuri Turan, Emel Bozkaya, Selim Badur
Journal of Medical Virology, Volume 81, Issue 9, Date: September 2009, Pages: 1645-1651
Influenza A virus in Taiwan, 1980-2006: Phylogenetic and antigenic characteristics of the hemagglutinin gene
Sheng-Fan Wang, Yuan-Ming Lee, Yu-Jiun Chan, Hsin-Fu Liu, Yung-Fong Yen, Wu-Tse Liu, Jason C. Huang, Yi-Ming Arthur Chen
Journal of Medical Virology, Volume 81, Issue 8, Date: August 2009, Pages: 1457-1470
Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: A randomized placebo-controlled trial
Herman J.M. Cools, Jacobijn Gussekloo, Joyce E.M. Remmerswaal, Ed J. Remarque, Aloys C.M. Kroes
Journal of Medical Virology, Volume 81, Issue 5, Date: May 2009, Pages: 908-914
A Major Concern for Pregnant Women
Amy Labant, Julia A. Greenawalt
Nursing for Women's Health
The fight against new types of influenza virus
Biotechnology Journal, Volume 1 Issue 12, Pages 1381 – 1392
Influenza type A in humans, mammals and birds: Determinants of virus virulence, host-range and interspecies transmission
Bioessays, Volume 25 Issue 7, Pages 657 – 671
Antiviral effects of Glycyrrhiza species
Phytotherapy Research, Volume 22 Issue 2, Pages 141 – 148
Paul S. Wikramaratna, Sunetra Gupta
Cellular Microbiology - Early View, Date: May 2009
An Improvised Oxygen Supply System for Pandemic and Disaster Use
Charles M. Little, Mark Merritt, Allen Wentworth
Academic Emergency Medicine - Early View, Date: April 2009
Effect of rapid influenza testing on the clinical management of paediatric influenza
Lance C. Jennings et al.
Influenza and Other Respiratory Viruses - Volume 3, Issue 3, Date: May 2009, Pages: 91-98
Assessing Infection Control Measures for Pandemic Influenza
Lawrence M. Wein, Michael P. Atkinson
Risk Analysis - Early View, Date: April 2009
Near-patient assays for diagnosis of influenza virus infection in adult patients
C. Steininger, M. Redlberger, W. Graninger, M. Kundi, T. Popow-Kraupp
Clinical Microbiology and Infection - Volume 15, Issue 3, Date: March 2009, Pages: 267-273
Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems
Lynnette Brammer, Alicia Budd, Nancy Cox
Influenza and Other Respiratory Viruses - Volume 3, Issue 2, Date: March 2009, Pages: 51-58
Managing public health crises: the role of models in pandemic preparedness
Seyed M. Moghadas, Nick J. Pizzi, Jianhong Wu, Ping Yan
Influenza and Other Respiratory Viruses - Volume 3, Issue 2, Date: March 2009, Pages: 75-79
Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model
Beate Sander et al.
Value in Health - Volume 12, Issue 2, Date: March/April 2009, Pages: 226-233
Viral kinetics and exhaled droplet size affect indoor transmission dynamics of influenza infection
S. C. Chen, C. P. Chio, L. J. Jou, C. M. Liao
Indoor Air - Early View, Date: February 2009
Death and serious illness following influenza vaccination: a multidisciplinary investigation
Alison Rue-Cover et al.
Pharmacoepidemiology and Drug Safety - Early View
Should Health-Care Providers in the United States Have Access to Influenza Vaccines Formulated for the Southern Hemisphere?
Raymond A. Strikas, Phyllis E. Kozarsky, Christie Reed, Brian K. Kapella, David O. Freedman
Journal of Travel Medicine - Volume 15, Issue 6, Date: November/December 2008, Pages: 442-446
Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria
Shuo Shen et al.
Journal of Medical Virology - Volume 80, Issue 11, Date: November 2008, Pages: 1972-1983
Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans
Julian W. Tang, Karry L.K. Ngai, Paul K.S. Chan
Journal of Medical Virology - Volume 80, Issue 11, Date: November 2008, Pages: 1992-1996
Acute necrotizing encephalopathy: A comparison between influenza and non-influenza cases
Akihisa Okumura, Sinpei Abe, Hiroyuki Kidokoro and Masashi Mizuguchi
Microbiology and Immunology - Volume 53 Issue 5, Pages 277 - 280
Pandemic influenza and the
hospitalist: Apocalypse when?
James C. Pile, Steven M. Gordon
Journal of Hospital Medicine - Volume 1, Issue 2, Date: March/April 2006, Pages: 118-123
Book chapters from key Wiley-Blackwell titles
Characteristics of patients with H1N1 influenza
What are the typical presenting symptoms of patients with the novel H1N1 influenza initially detected in April 2009?
The initial outbreak of H1N1 influenza was characterized by symptoms similar to those seen in patients with seasonal influenza and by a low overall mortality. A very large number of patients with a mild form of the illness were likely not diagnosed. (LOE = 3b)
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360(25):2605-2615.
Swine influenza viruses contain genes from human, swine, and avian influenza A viruses. A new variant of influenza A (H1N1) was initially detected in April, 2009, and has gone on to cause a worldwide pandemic. This report describes the characteristics of the first 642 cases identified in 41 states. The median age of patients was 20 years, with a range of 3 months to 81 years; 40% of patients were between the ages of 10 to 18 years, and 35% between 19 and 50 years. Patients presented with fever (94%), cough (92%), sore throat (66%), diarrhea (25%), and vomiting (25%); data were available regarding symptoms for 50% to 66% of patients, depending on the symptom. Hospitalization status was known for 399 patients, of whom 9% were hospitalized, with an age range of 19 months to 51 years. Many of the hospitalized patients had chronic medical conditions. The virus was sensitive to both oseltamivir and zanamivir. At the time of this writing (June 30, 2009) the CDC reported 27,717 confirmed or probable cases and 127 deaths (0.4%).